Vascular anastomosis is a logical target for autonomous surgery: a clearly defined task involving relatively geometric structures, with measurable steps and outcomes. It may offer a more manageable entry point for autonomy than the broader challenges of robotic soft-tissue surgery.
So Aleph is taking a different approach. Rather than developing another teleoperated microsurgical robot, it aims to use embodied AI to learn and perform surgical tasks autonomously. Its early demonstrations of autonomous vascular anastomosis suggest a potential shift from improving the surgeon’s dexterity to automating the procedure itself.
We have discussed the challenges autonomous systems face when entering soft-tissue robotics, as well as the strategies for overcoming them. Aleph is an interesting case to follow. But this is still very early. Research-stage demonstrations are a long way from reproducible performance, clinical validation, and routine surgical use. Will it make it through?
J Granell. Oct 2, 2026